HIV-1 drug-resistant mutations and related risk factors among HIV-1-positive individuals experiencing treatment failure in Hebei Province, China
Open Access
- 23 January 2017
- journal article
- research article
- Published by Springer Nature in AIDS Research and Therapy
- Vol. 14 (1) , 1-13
Abstract
To understand HIV-1 drug resistance in 11 prefectures of Hebei Province, China, we implemented a cross-sectional HIV-1 molecular epidemiological survey. Blood samples were collected from 122 newly diagnosed drug-naïve HIV-1-positive individuals and 229 antiretroviral therapy (ART)-failure individuals from 11 prefectures in Hebei Province, China. Patient demographic data were obtained via face-to-face interviews using a standardized questionnaire when blood samples were collected. Genotyping of HIV-1 drug resistance (DR) was implemented using an in-house assay. In this study, the overall prevalence of HIV-1 DR was 35.5%. The prevalence of HIV-1 DR in participants experiencing treatment failure and ART-naïve participants was 51.9 and 5.9%, respectively. Mutations in protease inhibitors, nucleoside reverse transcriptase inhibitors (NRTIs), and non-NRTI (NNRTIs), as well as dual and multiple mutations were extensively seen in participants experiencing treatment failure. The proportions of NNRTI mutations (χ2 = 9.689, p = 0.002) and dual mutations in NRTIs and NNRTIs (χ2 = 39.958, p < 0.001) in participants experiencing treatment failure were significantly higher than those in ART-naïve participants. The distributions of M184V/I and M41L mutations differed significantly among three main HIV-1 genotypes identified. Viral load, symptoms in the past 3 months, CD4 counts, transmission route, and the duration of ART were found to be associated with HIV-1 DR. Our results suggest that new prevention and control strategies should be formulated according to the epidemic characteristics of HIV-1-resistant strains in Hebei Province, where antiretroviral drugs are widely used.Keywords
Funding Information
- Our study was implemented with the support of the Natural Science Fund of Hebei Province (H2016303006)
This publication has 26 references indexed in Scilit:
- Different Distribution of HIV-1 Subtype and Drug Resistance Were Found among Treatment Naïve Individuals in Henan, Guangxi, and Yunnan Province of ChinaPLOS ONE, 2013
- Prevalence and Mutation Patterns of HIV Drug Resistance from 2010 to 2011 among ART-Failure Individuals in the Yunnan Province, ChinaPLOS ONE, 2013
- A Comprehensive Mapping of HIV-1 Genotypes in Various Risk Groups and Regions across China Based on a Nationwide Molecular Epidemiologic SurveyPLOS ONE, 2012
- Estimating the number of people living with HIV/AIDS in China: 2003-09International Journal of Epidemiology, 2010
- Commentary: Not all attitudes are created equalInternational Journal of Epidemiology, 2010
- Long‐Term Trends of HIV Type 1 Drug Resistance Prevalence among Antiretroviral Treatment–Experienced Patients in SwitzerlandClinical Infectious Diseases, 2009
- The changing face of HIV in ChinaNature, 2008
- Electronic structure of the iron-based superconductor LaOFePNature, 2008
- Current progress of China's free ART programCell Research, 2005
- HIV infection and AIDS in China, 1985 through 1994.American Journal of Public Health, 1996